Osteopore (ASX:OSX) Market Cap: A$2.71 Mil (As of Jun. 25, 2026)


What is Osteopore Market Cap?

Osteopore ASX:OSX Market Cap is A$2.71 Mil as of Jun. 25, 2026. The stock has 7 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Osteopore ranks worse than 96.88% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Osteopore's share price for the quarter that ended in Dec. 2025 was A$0.0065. Osteopore's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 272.50 Mil. Therefore, Osteopore's market cap for the quarter that ended in Dec. 2025 was A$1.77 Mil.

Osteopore's quarterly market cap declined from Dec. 2024 (A$4.09 Mil) to Jun. 2025 (A$2.01 Mil) and declined from Jun. 2025 (A$2.01 Mil) to Dec. 2025 (A$1.77 Mil).

Osteopore's annual market cap declined from Dec. 2023 (A$6.82 Mil) to Dec. 2024 (A$4.09 Mil) and declined from Dec. 2024 (A$4.09 Mil) to Dec. 2025 (A$1.77 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Osteopore's Enterprise Value for Today is A$4.85 Mil.


Osteopore  (ASX:OSX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Osteopore Market Cap Related Terms


Osteopore Market Cap Historical Data

* Premium members only.

The historical data trend for Osteopore's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Osteopore Market Cap Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial 26.39 18.59 6.82 4.09 1.77

Osteopore Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.82 6.65 4.09 2.01 1.77

ASX:OSX vs ISRG, BDX, MDLN: Market Cap Comparison

For the Medical Instruments & Supplies subindustry, Osteopore's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Osteopore Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Market Cap distribution charts can be found below:

* The bar in red indicates where Osteopore's Market Cap falls into.



Osteopore Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Osteopore's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=A$0.0065*272.502
=A$1.77

Osteopore's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=A$0.0065*272.502
=A$1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of A$2.71 Mil mean?
Osteopore (ASX:OSX) has a Market Cap of A$2.71 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Osteopore and its competitors. According to the industry distribution chart, Osteopore ranks #839 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 96.9%.
Is Osteopore's Market Cap too high?
Osteopore's current Market Cap is A$2.71 Mil. Based on the distribution chart, Osteopore ranks #839 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Osteopore's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Osteopore ranks #839 out of 866 companies for Market Cap. This places Osteopore in the lower half of its industry. The industry median Market Cap is 122.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.56, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Osteopore and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osteopore's current Market Cap is A$2.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current Market Cap is A$2.71 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Market Cap is A$2.71 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Osteopore Business Description

Address 2 Tukang Innovation Grove, No. 09-06 and 07, JTC MedTech Hub, Singapore, SGP, 618305
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.